Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy U Lin

Showing results (321-330 of 330) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 330 results.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacyAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Neuro-Oncology|December 9, 2023
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistanceAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
JCO Precision Oncology|September 4, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8<sup>+</sup> and PD-1<sup>+</sup> Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk FactorsJoao V Alessi, James R Lindsay, Anita Giobbie-Hurder, et al.
Cancer Discovery|September 28, 2015
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic TargetsPriscilla K Brastianos, Scott L Carter, Sandro Santagata, et al.
Cancer Discovery|March 28, 2020
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung CancersBob T Li, Flavia Michelini, Sandra Misale, et al.
NPJ Precision Oncology|March 14, 2026
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancerPaolo Tarantino, Se-Eun Kim, Melissa E Hughes, et al.
Nature Communications|November 8, 2017
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumorsViktor A Adalsteinsson, Gavin Ha, Samuel S Freeman, et al.
Nature Medicine|March 29, 2025
Author Correction: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological featuresJohanna Klughammer, Daniel L Abravanel, Åsa Segerstolpe, et al.
Nature Medicine|October 31, 2024
A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological featuresJohanna Klughammer, Daniel L Abravanel, Åsa Segerstolpe, et al.
Nature Cancer|December 30, 2022
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasisSusana Garcia-Recio, Toshinori Hinoue, Gregory L Wheeler, et al.
Pageof 33

Showing results (321-330 of 330) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 330 results.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacyAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Neuro-Oncology|December 9, 2023
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistanceAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
JCO Precision Oncology|September 4, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8<sup>+</sup> and PD-1<sup>+</sup> Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk FactorsJoao V Alessi, James R Lindsay, Anita Giobbie-Hurder, et al.
Cancer Discovery|September 28, 2015
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic TargetsPriscilla K Brastianos, Scott L Carter, Sandro Santagata, et al.
Cancer Discovery|March 28, 2020
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung CancersBob T Li, Flavia Michelini, Sandra Misale, et al.
NPJ Precision Oncology|March 14, 2026
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancerPaolo Tarantino, Se-Eun Kim, Melissa E Hughes, et al.
Nature Communications|November 8, 2017
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumorsViktor A Adalsteinsson, Gavin Ha, Samuel S Freeman, et al.
Nature Medicine|March 29, 2025
Author Correction: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological featuresJohanna Klughammer, Daniel L Abravanel, Åsa Segerstolpe, et al.
Nature Medicine|October 31, 2024
A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological featuresJohanna Klughammer, Daniel L Abravanel, Åsa Segerstolpe, et al.
Nature Cancer|December 30, 2022
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasisSusana Garcia-Recio, Toshinori Hinoue, Gregory L Wheeler, et al.
Pageof 33